| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), IBIO's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 430.0K | - | - | |
| Dir | 38.0K | - | - | |
| Dir | 38.0K | - | - | |
| Dir | 38.0K | - | - | |
| Dir | 38.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | Banjak Marc | Chief Legal Officer | Buy | 13,934 | $1.65 | $23,055.09 | +125.9% | - | - | |
| Mar 19, 2026 | Brenner Martin87 | See Remarks | Buy | 12,336 | $2.02 | $24,918.72 | +67.4% | - | - | |
| Mar 19, 2026 | Duran Felipe | Chief Financial Officer | Buy | 24,835 | $2.02 | $50,131.93 | +223.0% | - | - | |
| Jan 10, 2025 | Sender Gary | Director | Buy | 9,191 | $2.72 | $24,999.52 | New | -52.5% | +5.9% | |
| Jan 10, 2025 | Arkowitz David61 | Director | Buy | 18,382 | $2.72 | $49,999.04 | New | -52.5% | +5.9% | |
| Jan 10, 2025 | Duran Felipe | Chief Financial Officer | Buy | 9,191 | $2.72 | $24,999.52 | +471.8% | -52.5% | +5.9% | |
| Jan 10, 2025 | Banjak Marc | Chief Legal Officer | Buy | 9,191 | $2.72 | $24,999.52 | +490.2% | -52.5% | +5.9% | |
| Jan 10, 2025 | Parada Antonio Bernardino Guimaraes | Director | Buy | 183,823 | $2.72 | $499,998.56 | New | -52.5% | +5.9% | |
| Jan 10, 2025 | Clark William D | Director | Buy | 1,838 | $2.72 | $4,999.36 | New | -52.5% | +5.9% | |
| Jan 10, 2025 | Brenner Martin87 | See Remarks | Buy | 9,191 | $2.72 | $24,999.52 | +100.7% | -52.5% | +5.9% |